Today news
About the same in other media
Will Novavax be the fifth COVID vaccine approved for use in the EU?
Reading now: 976
The European union's drugs regulator will on Monday decide whether to authorise the use of Novavax's vaccine against COVID-19 which its manufacturer claims can help win over vaccine sceptics.
If approved by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use, Novavax will be the fifth vaccine authorised across the bloc alongside Pfizer/BioNTech, AstraZeneca/Oxford, Moderna, and Johnson & Johnson.
Novavax uses a more conventional technology than those used for the other vaccines already in use — it is similar to the technology used in the decades-old hepatitis B and pertussis vaccines — and does not need to be stored at ultra-low temperatures.
The so-called protein "subunit" vaccine contains purified fragments
Read more on euronews.comAbout this in other media
Covid-19 Marches Toward Endemic Status in U.S. as Omicron Spreads wsj.com /2 years ago
Watch live: Ukraine and COVID on the agenda as Putin delivers annual speech euronews.com /2 years ago
COVID in Europe: Belgium closes cinemas as Spain brings back masks euronews.com /2 years ago
Show more
The website finance-news.co is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
